LK-3

General Information


DRACP ID  DRACP04064

Peptide Name   LK-3

Sequence  LKKLCKLLKKLCKLAG,LKKLCKLLKKLCKLAG

Sequence Length  33

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antiviral



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Acetylation,Acetylation

C-terminal Modification  Amidation,Amidation

Other Modification  None

Chiral  Mix



Physicochemical Information


Formula  C166H312N44O32S4

Absent amino acids  DEFHIMNPQRSTVWY

Common amino acids  KL

Mass  413584

Pl  10.95

Basic residues  12

Acidic residues  0

Hydrophobic residues  14

Net charge  12

Boman Index  306

Hydrophobicity  35.15

Aliphatic Index  147.88

Half Life 
  /

Extinction Coefficient cystines  250

Absorbance 280nm  7.81

Polar residues  6

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 25056130

Title  Cell-penetrating, dimeric δΌͺ-helical peptides: nanomolar inhibitors of HIV-1 transcription

Doi Not available

Year  2014

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  16542

DRACP is developed by Dr.Zheng's team.